Rachael McGovern
- BIOGRAPHY
- Insights
Rachael McGovern provides counsel to clients on a host of business, regulatory, and transactional matters. She routinely advises hospitals, nursing homes and other long term care facilities, ambulatory surgery centers, diagnostic imaging facilities, physician, dental and ancillary service providers (including, therapy, behavioral health, and home care providers), and other for-profit and not-for-profit clients.
Prior to joining the firm, Rachael was an Associate at a boutique corporate law firm in New York where she was involved in various real estate and asset purchase transactions and assisted in the formation of both for-profit and not-for-profit corporations.
While in law school, Rachael worked as a student attorney in the Amelia A. Gould Representation in Mediation clinic under a New York State Practice Order in which she provided pro bono legal advice to pro se litigants in court-ordered mediations in the Southern District of New York and the Surrogate’s Court of Westchester County.
In a surprising new development that comes just days after a temporary ban on the Corporate Transparency Act's (CTA) beneficial ownership information (BOI) reporting requirements was lifted, the U.S. Department of the Treasury (Treasury Department), Financial Crimes Enforcement Network (FinCEN) announced in a March 2nd press release that it will not enforce the BOI reporting requirements against U.S. citizens and domestic reporting companies.
Following nearly a year of legal challenges, the beneficial ownership information (BOI) reporting requirements under the Corporate Transparency Act (CTA) are once again back in effect, with a current filing deadline of March 21, 2025.
In a recent ruling, the New Jersey Supreme Court concluded that the “self-critical analysis” privilege under the Patient Safety Act (“PSA”) and its implementing regulations can only be applicable if the information sought was generated for purposes of an independent patient safety committee that is created solely for the purposes of the PSA (i.e., the information […]
Pursuant to the New Jersey Applied Behavior Analyst Licensing Act (the “Act”), the Board of Applied Behavior Analyst Examiners (the “Board”) published the official rules concerning the practice of Applied Behavior Analyst (“ABA”) therapy, effective May 6, 2024 (the “Rules”).
On March 1, 2024, the United States District Court for the Northern District of Alabama declared the Corporate Transparency Act (CTA) unconstitutional.
Rachael McGovern provides counsel to clients on a host of business, regulatory, and transactional matters. She routinely advises hospitals, nursing homes and other long term care facilities, ambulatory surgery centers, diagnostic imaging facilities, physician, dental and ancillary service providers (including, therapy, behavioral health, and home care providers), and other for-profit and not-for-profit clients.
Prior to joining the firm, Rachael was an Associate at a boutique corporate law firm in New York where she was involved in various real estate and asset purchase transactions and assisted in the formation of both for-profit and not-for-profit corporations.
While in law school, Rachael worked as a student attorney in the Amelia A. Gould Representation in Mediation clinic under a New York State Practice Order in which she provided pro bono legal advice to pro se litigants in court-ordered mediations in the Southern District of New York and the Surrogate’s Court of Westchester County.
Pursuant to the New Jersey Applied Behavior Analyst Licensing Act (the “Act”), the Board of Applied Behavior Analyst Examiners (the “Board”) published the official rules concerning the practice of Applied Behavior Analyst (“ABA”) therapy, effective May 6, 2024 (the “Rules”).
On March 1, 2024, the United States District Court for the Northern District of Alabama declared the Corporate Transparency Act (CTA) unconstitutional.
In a recent ruling, the New Jersey Supreme Court concluded that the “self-critical analysis” privilege under the Patient Safety Act (“PSA”) and its implementing regulations can only be applicable if the information sought was generated for purposes of an independent patient safety committee that is created solely for the purposes of the PSA (i.e., the information […]
Following nearly a year of legal challenges, the beneficial ownership information (BOI) reporting requirements under the Corporate Transparency Act (CTA) are once again back in effect, with a current filing deadline of March 21, 2025.
In a surprising new development that comes just days after a temporary ban on the Corporate Transparency Act's (CTA) beneficial ownership information (BOI) reporting requirements was lifted, the U.S. Department of the Treasury (Treasury Department), Financial Crimes Enforcement Network (FinCEN) announced in a March 2nd press release that it will not enforce the BOI reporting requirements against U.S. citizens and domestic reporting companies.
In a surprising new development that comes just days after a temporary ban on the Corporate Transparency Act's (CTA) beneficial ownership information (BOI) reporting requirements was lifted, the U.S. Department of the Treasury (Treasury Department), Financial Crimes Enforcement Network (FinCEN) announced in a March 2nd press release that it will not enforce the BOI reporting requirements against U.S. citizens and domestic reporting companies.
Following nearly a year of legal challenges, the beneficial ownership information (BOI) reporting requirements under the Corporate Transparency Act (CTA) are once again back in effect, with a current filing deadline of March 21, 2025.
In a recent ruling, the New Jersey Supreme Court concluded that the “self-critical analysis” privilege under the Patient Safety Act (“PSA”) and its implementing regulations can only be applicable if the information sought was generated for purposes of an independent patient safety committee that is created solely for the purposes of the PSA (i.e., the information […]
Pursuant to the New Jersey Applied Behavior Analyst Licensing Act (the “Act”), the Board of Applied Behavior Analyst Examiners (the “Board”) published the official rules concerning the practice of Applied Behavior Analyst (“ABA”) therapy, effective May 6, 2024 (the “Rules”).
On March 1, 2024, the United States District Court for the Northern District of Alabama declared the Corporate Transparency Act (CTA) unconstitutional.
Education
Court admissions
AWARDS & RANKINGS
Pace University School of Law, Excellence in Clinical Education Award, 2021-2022